Detalhe da pesquisa
1.
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
N Engl J Med
; 389(3): 215-227, 2023 Jul 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37467497
2.
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
J Infect Dis
; 220(1): 105-115, 2019 06 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30778554
3.
Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides.
Hum Vaccin Immunother
; 20(1): 2311480, 2024 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38608171
4.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32891191
5.
Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
mSphere
; 3(4)2018 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30089644
6.
Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to Streptococcus pneumoniae Capsular Polysaccharides.
mSphere
; 3(4)2018 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30089645
7.
Evaluation of approaches to monitor Staphylococcus aureus virulence factor expression during human disease.
PLoS One
; 10(2): e0116945, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25719409